Misplaced Pages

#571428

31-547: CPRA may refer to: Central progressive retinal atrophy, a type of progressive retinal atrophy (eye problem) California Privacy Rights Act , a privacy and data protection law California Public Records Act , a freedom-of-information law Canadian Professional Rodeo Association , Canadian governing body of professional rodeo Louisiana Coastal Protection and Restoration Authority , an environmental authority with jurisdiction over Louisiana's coastal region Topics referred to by

62-457: A disease -causing mutation is the proportion of individuals with the mutation that exhibit clinical symptoms among all individuals with such mutation.  For example: If a mutation in the gene responsible for a particular autosomal dominant disorder has 95% penetrance, then 95% of those with the mutation will go on to develop the disease, showing its phenotype, whereas 5% will not.   Penetrance only refers to whether an individual with

93-511: A different estimated penetrance dependent on the age. A specific hexanucleotide repeat expansion within the C9orf72 gene said to be a major cause for developing amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is an example of a genotype with age dependent penetrance. The genotype is said to be non-penetrant until the age of 35, 50% penetrant by the age of 60, and almost completely penetrant by age 80. For some mutations,

124-520: A genetic test, animals of breeds susceptible to PRA can be cleared of the disease only by the passage of time—that is, by living past the age at which PRA symptoms are typically apparent in their breed. Breeds in which the PRA gene is recessive may still be carriers of the gene and pass it on to their offspring, however, even if they lack symptoms, and it is also possible for onset of the disease to be later than expected, making this an imperfect test at best. There

155-504: A key role in the cause of promotor hypermethylation of the BRCA1 gene in the affected twin, which caused the cancer.     It can be challenging to estimate the penetrance of a specific genotype due to all the influencing factors. In addition to the factors mentioned above there are several other considerations that must be taken into account when penetrance is determined: Penetrance estimates can be affected by ascertainment bias if

186-479: A mutation in the LHCGR gene, is an example of a genotype only penetrant in males. Meaning that males with this particular genotype exhibit symptoms of the disease whilst the same genotype is nonpenetrant in females. Genetic modifiers are genetic variants or mutations able to modify a primary disease-causing variant's phenotypic outcome without being disease causing themselves. For instance, in single gene disorders there

217-462: A specific genotype exhibit symptoms or signs of disease, whilst others do not. If clinical signs associated with a specific genotype appear more frequently with increasing age, the penetrance is said to be age dependent. Some diseases are non-penetrant up until a certain age and then the penetrance starts to increase drastically, whilst others exhibit low penetrance at an early age and continue to increase with time. For this reason, many diseases have

248-415: A specific genotype exhibits any phenotypic signs or symptoms, and is not to be confused with variable expressivity which is to what extent or degree the symptoms for said disease are shown (the expression of the phenotypic trait). Meaning that, even if the same disease-causing mutation affects separate individuals, the expressivity will vary. If 100% of individuals carrying a particular genotype express

279-460: Is an inherited condition (in the Labrador Retriever it is inherited as an autosomal dominant trait with variable penetrance ). CPRA occurs in older dogs. Peripheral vision is retained for a long time. Vision is better in low light and better for moving or distant objects. Not all affected dogs go blind. Secondary cataracts are common. It can also be found in the poodle varieties There

310-565: Is another retinal disease in Briards known as hereditary retinal dysplasia. These dogs are night blind from birth, and day vision varies. Puppies affected often have nystagmus . It is also known as lipid retinopathy . Progressive vision loss in any dog in the absence of canine glaucoma or cataracts can be an indication of PRA. It usually starts with decreased vision at night, or nyctalopia . Other symptoms include dilated pupils and decreased pupillary light reflex . Fundoscopy to examine

341-414: Is caused by a defect in the gene for cGMP- phosphodiesterase , which leads to retinal levels of cyclic guanosine monophosphate ten times normal. This is caused by an abnormal development of both rod and cone cells. Dogs are initially night blind and then progress to day blindness. This is a disease with normal rod and cone cell development but late onset degeneration of the rod cells that progresses to

SECTION 10

#1732847911572

372-447: Is different from Wikidata All article disambiguation pages All disambiguation pages Progressive retinal atrophy In general, PRAs are characterised by initial loss of rod photoreceptor cell function followed by that of the cones and for this reason night blindness is the first significant clinical sign for most dogs affected with PRA. As other retinal disorders, PRA can be divided into either dysplastic disease, where

403-531: Is likely to be caused by a combination of genetic, environmental and lifestyle factors.   BRCA1 is an example of a genotype with reduced penetrance. By age 70, the mutation is estimated to have a breast cancer penetrance of around 65% in women. Meaning that about 65% of women carrying the gene will develop breast cancer by the time they turn 70. Many factors such as age, sex, environment, epigenetic modifiers, and modifier genes are linked to penetrance. These factors can help explain why certain individuals with

434-415: Is no treatment for PRA. However, most dogs that suffer from this disease adjust remarkably well. To maximize the quality of the dog's life, follow these guidelines: Penetrance Penetrance in genetics is the proportion of individuals carrying a particular variant (or allele ) of a gene ( genotype ) that also expresses an associated trait ( phenotype ). In medical genetics , the penetrance of

465-503: Is one gene primarily responsible for development of the disease, but modifier genes inherited separately can affect the phenotype. Meaning that the presence of a mutation located on a loci different from the one with the disease-causing mutation, may either hinder manifestation of the phenotype or alter the mutations effects, and thereby influencing the penetrance. Exposure to environmental and lifestyle factors such as chemicals , diet , alcohol intake , drugs and stress are some of

496-460: The DNA sequence, but from epigenetic alterations such as DNA methylation or histone modifications . Epigenetic differences may therefore be one of the factors contributing to reduced penetrance.  A study done on a pair of genetically identical monozygotic twins , where one twin got diagnosed with leukemia and later on thyroid carcinoma whilst the other had no registered illnesses, showed that

527-523: The cells develop abnormally, and degenerative, where the cells develop normally but then degenerate during the dog's lifetime. Generalized PRA is the most common type and causes atrophy of all the neural retinal structures. Central progressive retinal atrophy (CPRA) is a different disease from PRA involving the retinal pigment epithelium (RPE), and is also known as retinal pigment epithelial dystrophy (RPED). Commonly affected breeds: This type of PRA has an early onset of severe vision loss. It

558-526: The BRCA2 mutation is an example of a disease with gender-related penetrance. The penetrance is determined to be much higher in women than men. By age 70, around 86% of females in contrast to 6% of males with the same mutation is estimated to develop breast cancer. In cases where clinical symptoms or the phenotype related to a genetic mutation are present only in one sex, the disorder is said to be sex-limited. Familial male-limited precocious puberty (FMPP) caused by

589-468: The RPE and loss of function. The loss of function of the RPE leads to photoreceptor degeneration. Vitamin E deficiency may play a role in the development of CPRA. It is characterized by accumulation of pigment spots in the retina surrounded by retinal atrophy and a mottled appearance of the pigmented nontapetal fundus. The pigmented spots eventually coalesce and fade as the atrophy of the retina increases. It

620-467: The affected twin had increased methylation levels of the BRCA 1 gene. The research concluded that the family had no known DNA-repair syndrome or any other hereditary diseases in the last four generations, and no genetic differences between the studied pair of monozygotic twins were detected in the BRCA1 regulatory region. This indicates that epigenetic changes caused by environmental or behavioral factors had

651-432: The associated trait, the genotype is said to show complete penetrance. Neurofibromatosis type 1 (NF1) , is an autosomal dominant condition which shows complete penetrance, consequently everyone who inherits the disease-causing variant of this gene will develop some degree of symptoms for NF1. The penetrance is said to be reduced if less than 100% of individuals carrying a particular genotype express associated traits, and

SECTION 20

#1732847911572

682-416: The cause as to how different paths lead to the same phenotypic display. When similar phenotypes can be observed but by different causes, it is called phenocopies . Phenocopies is when environmental and/or behavioral modifiers causes an illness which mimics the phenotype of a genetic inherited disease. Because of phenocopies, determining the degree of penetrance for a genetic disease requires full knowledge of

713-403: The clinical phenotypic traits related to its mutation (taking into consideration the expressivity), but the signs or symptoms displayed by a specific affected individual can often be similar to other unrelated phenotypical traits. Taking into consideration the effect that environmental or behavioral modifiers have, and how they can impact the cause of a mutation or epigenetic alteration, we now have

744-435: The cone cells. It is inherited as an autosomal recessive trait and has been linked to the ninth canine chromosome . This condition is linked to the X chromosome . CPRA is also known as retinal pigment epithelial dystrophy (RPED). The cause of this condition is the loss of the retinal pigment epithelium's ability to effectively process the photoreceptor outer segment (POS) and subsequent accumulation of POS material in

775-473: The factors that might influence disease penetrance. For example, several studies of BRCA1 and BRCA2 mutations, associated with an elevated risk of breast and ovarian cancer in women, have examined associations with environmental and behavioral modifiers such as pregnancies , history of breast feeding , smoking , diet, and so forth. Sometimes, genetic alterations which can cause genetic disease and phenotypic traits, are not from changes related directly to

806-460: The individuals attending the studies, and the factors that may or may not have caused their illness.       For example, new research on Hypertrophic Cardiomyopathy ( HCM ) based on a technique called Cardiac Magnetic Resonance (CMR), describes how various genetic illnesses that showcase the same phenotypic traits as HCM, are actually phenocopies. Previously these phenocopies were all diagnosed and treated, thought to arrive from

837-475: The penetrance. Large-scale population-based studies, which use both genetic sequencing and phenotype data from large groups of people, is a different method for determining penetrance. This method offers less upward bias compared to family-based studies and is more accurate the larger the sample population is. These studies may contain a healthy-participant-bias which can lead to lower penetrance estimates. A genotype with complete penetrance will always display

868-429: The phenotype is more frequently present in one sex and in rare cases mutations appear completely non-penetrant in a particular gender. This is called gender-related penetrance or sex-dependent penetrance and may be the result of allelic variation, disorders in which the expression of the disease is limited to organs only found in one sex such as testis or ovaries, or sex steroid-responsive genes. Breast cancer caused by

899-508: The retina will show shrinking of the blood vessels, decreased pigmentation of the nontapetal fundus , increased reflection from the tapetum due to thinning of the retina, and later in the disease a darkened, atrophied optic disc . Secondary cataract formation in the posterior portion of the lens can occur late in the disease. In these cases diagnosis of PRA may require electroretinography (ERG). For many breeds there are specific genetic tests of blood or buccal mucosa for PRA. Absent

930-405: The same term [REDACTED] This disambiguation page lists articles associated with the title CPRA . If an internal link led you here, you may wish to change the link to point directly to the intended article. Retrieved from " https://en.wikipedia.org/w/index.php?title=CPRA&oldid=1252192532 " Category : Disambiguation pages Hidden categories: Short description

961-456: The sampling is not systematic. Traditionally a phenotype-driven approach focusing on individuals with a given condition and their family members has been used to determine penetrance. However, it may be difficult to transfer these estimates over to the general population because family members may share other genetic and/or environmental factors that could influence manifestation of said disease, leading to ascertainment bias and an overestimation of

CPRA - Misplaced Pages Continue

#571428